Skip to main content
Ilyas Sahin, MD, Oncology, Boston, MA

IlyasSahinMD

Oncology Boston, MA

Gastrointestinal Cancer

Physician

Dr. Sahin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sahin's full profile

Already have an account?

  • Office

    55 Fruit St
    Boston, MA 02114
    Phone+1 617-726-2000

Education & Training

  • Brown University
    Brown UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020
  • Mount Auburn Hospital
    Mount Auburn HospitalResidency, Internal Medicine, 2017
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2017
  • Hacettepe University FOM
    Hacettepe University FOMClass of 2011

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2024 - 2026
  • FL State Medical License
    FL State Medical License 2021 - 2025
  • RI State Medical License
    RI State Medical License 2017 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • New Combination of Anti-CXCR4 and Anti-PD1 Therapy Shows Promise for Liver Cancer Treatment
    New Combination of Anti-CXCR4 and Anti-PD1 Therapy Shows Promise for Liver Cancer TreatmentDecember 16th, 2024
  • Research Spotlight: Improving Liver Cancer Outcomes Through Enhanced Immunotherapy
    Research Spotlight: Improving Liver Cancer Outcomes Through Enhanced ImmunotherapyDecember 13th, 2024
  • In HCC with Bone Metastases, Multiple Factors Drive Survival
    In HCC with Bone Metastases, Multiple Factors Drive SurvivalSeptember 21st, 2023